Regulatory Calendar

Track upcoming FDA meetings, PDUFA dates, and regulatory milestones for pharma products.

Summary: Gilead has 2 PDUFA dates in Q2 2026, 1 FDA advisory committee meeting, and 3 regulatory submissions planned. Recent milestone: Veklury label expansion approved Jan 2026.
Date Event Drug Sponsor Status
2026-03-15 PDUFA Date Lenacapavir Gilead Upcoming
2026-04-10 FDA AdComm Trodelvy Gilead Upcoming
2026-01-20 Label Expansion Approved Veklury Gilead Completed
Upcoming Milestones
  • Lenacapavir PDUFA: Mar 15, 2026
  • Trodelvy AdComm: Apr 10, 2026
  • Veklury label expansion approved Jan 2026
Regulatory Breakdown
  • PDUFA Dates: 2
  • AdComm Meetings: 1
  • Submissions Planned: 3
Back to Dashboard